Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome

Detalhes bibliográficos
Autor(a) principal: RAUBER,MARIANA R.
Data de Publicação: 2019
Outros Autores: PILGER,DIOGO A., CECCONELLO,DAIANE K., FALCETTA,FREDERICO S., MARCONDES,NATÁLIA A., FAULHABER,GUSTAVO A.M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais da Academia Brasileira de Ciências (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652019000300803
Resumo: Abstract: Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects.
id ABC-1_f42cd5343314b7a7b9f337279ef23c10
oai_identifier_str oai:scielo:S0001-37652019000300803
network_acronym_str ABC-1
network_name_str Anais da Academia Brasileira de Ciências (Online)
repository_id_str
spelling Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndromediagnostic screeningferritinhepcidinironmetabolic syndromeAbstract: Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects.Academia Brasileira de Ciências2019-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652019000300803Anais da Academia Brasileira de Ciências v.91 n.2 2019reponame:Anais da Academia Brasileira de Ciências (Online)instname:Academia Brasileira de Ciências (ABC)instacron:ABC10.1590/0001-3765201920180286info:eu-repo/semantics/openAccessRAUBER,MARIANA R.PILGER,DIOGO A.CECCONELLO,DAIANE K.FALCETTA,FREDERICO S.MARCONDES,NATÁLIA A.FAULHABER,GUSTAVO A.M.eng2019-05-08T00:00:00Zoai:scielo:S0001-37652019000300803Revistahttp://www.scielo.br/aabchttps://old.scielo.br/oai/scielo-oai.php||aabc@abc.org.br1678-26900001-3765opendoar:2019-05-08T00:00Anais da Academia Brasileira de Ciências (Online) - Academia Brasileira de Ciências (ABC)false
dc.title.none.fl_str_mv Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
spellingShingle Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
RAUBER,MARIANA R.
diagnostic screening
ferritin
hepcidin
iron
metabolic syndrome
title_short Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title_full Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title_fullStr Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title_full_unstemmed Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
title_sort Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
author RAUBER,MARIANA R.
author_facet RAUBER,MARIANA R.
PILGER,DIOGO A.
CECCONELLO,DAIANE K.
FALCETTA,FREDERICO S.
MARCONDES,NATÁLIA A.
FAULHABER,GUSTAVO A.M.
author_role author
author2 PILGER,DIOGO A.
CECCONELLO,DAIANE K.
FALCETTA,FREDERICO S.
MARCONDES,NATÁLIA A.
FAULHABER,GUSTAVO A.M.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv RAUBER,MARIANA R.
PILGER,DIOGO A.
CECCONELLO,DAIANE K.
FALCETTA,FREDERICO S.
MARCONDES,NATÁLIA A.
FAULHABER,GUSTAVO A.M.
dc.subject.por.fl_str_mv diagnostic screening
ferritin
hepcidin
iron
metabolic syndrome
topic diagnostic screening
ferritin
hepcidin
iron
metabolic syndrome
description Abstract: Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects.
publishDate 2019
dc.date.none.fl_str_mv 2019-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652019000300803
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652019000300803
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0001-3765201920180286
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Ciências
publisher.none.fl_str_mv Academia Brasileira de Ciências
dc.source.none.fl_str_mv Anais da Academia Brasileira de Ciências v.91 n.2 2019
reponame:Anais da Academia Brasileira de Ciências (Online)
instname:Academia Brasileira de Ciências (ABC)
instacron:ABC
instname_str Academia Brasileira de Ciências (ABC)
instacron_str ABC
institution ABC
reponame_str Anais da Academia Brasileira de Ciências (Online)
collection Anais da Academia Brasileira de Ciências (Online)
repository.name.fl_str_mv Anais da Academia Brasileira de Ciências (Online) - Academia Brasileira de Ciências (ABC)
repository.mail.fl_str_mv ||aabc@abc.org.br
_version_ 1754302867612631040